These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Stroke prevention in elderly patients with atrial fibrillation. Lew SJ; Lim JK Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065 [TBL] [Abstract][Full Text] [Related]
7. End-stage renal disease with atrial fibrillation: uncharted territory in the modern world of anticoagulants. Browne SD; McMaster J; Rizvi SA; Ahmed S Expert Opin Pharmacother; 2014 Aug; 15(12):1639-42. PubMed ID: 25032883 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation control in atrial fibrillation: optimizing risks and benefits. Alsheikh-Ali AA; Estes NA Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):72-3. PubMed ID: 20031792 [No Abstract] [Full Text] [Related]
9. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk]. Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287 [TBL] [Abstract][Full Text] [Related]
12. Dilemmas in the management of atrial fibrillation in chronic kidney disease. Reinecke H; Brand E; Mesters R; Schäbitz WR; Fisher M; Pavenstädt H; Breithardt G J Am Soc Nephrol; 2009 Apr; 20(4):705-11. PubMed ID: 19092127 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision. Singer DE Proc Assoc Am Physicians; 1996 Jan; 108(1):29-36. PubMed ID: 8834062 [TBL] [Abstract][Full Text] [Related]
14. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859 [TBL] [Abstract][Full Text] [Related]
15. Preventing stroke in atrial fibrillation. Wolf PA; Singer DE Am Fam Physician; 1997 Dec; 56(9):2242-50. PubMed ID: 9402810 [TBL] [Abstract][Full Text] [Related]
16. Outcome of atrial fibrillation among patients with end-stage renal disease. Chou CY; Kuo HL; Wang SM; Liu JH; Lin HH; Liu YL; Huang CC Nephrol Dial Transplant; 2010 Apr; 25(4):1225-30. PubMed ID: 19923144 [TBL] [Abstract][Full Text] [Related]
17. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. Marinigh R; Lane DA; Lip GY J Am Coll Cardiol; 2011 Mar; 57(12):1339-48. PubMed ID: 21414530 [TBL] [Abstract][Full Text] [Related]
18. Role of anticoagulant therapy in atrial fibrillation. Kottkamp H; Hindricks G; Breithardt G J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S86-96. PubMed ID: 9727682 [TBL] [Abstract][Full Text] [Related]
19. [Anticoagulation in patients with atrial fibrillation]. Mügge A Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. Lip GY Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056 [No Abstract] [Full Text] [Related] [Next] [New Search]